Genenta Science S.p.A GNTA
NASDAQ GNTA
$1.19 -0.03 (-2.46%)
At close: Aug 20, 2026 · 4:00 PM EDT

Genenta Science S.p.A (GNTA) Raw Materials (2022)

Genenta Science S.p.A (GNTA) posted Raw Materials of $41320.0 for Q4 2022.

Genenta Science S.p.A (GNTA) Raw Materials (2022) Analysis & Trends

Genenta Science S.p.A has reported Raw Materials for 1 years, with the latest figure at $41320.0 in Q4 2022.

  • Quarterly Raw Materials changed N/A year-over-year to $41320.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $41320.0 (changed N/A YoY) and the FY2022 annual result came in at $41320.0, changed N/A from the prior year.
  • Raw Materials held at $41320.0 in Q4 2022 per GNTA's latest filing.
  • Over five years, Raw Materials peaked at $41320.0 in Q4 2022 and troughed at $41320.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Genenta Science S.p.A 23.36 Mn -35.73 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 41,320.02